A leading cell and gene therapy solutions provider, we offer fully integrated, end-to-end services. We leverage our AAV expertise to partner with companies in the delivery of life-saving and life-altering treatments.
To view current career opportunities at Oxford Biomedica Solutions, please visit our LinkedIn page.
How We’re Different
Inquisitive by nature, we strive to find ideal solutions to your AAV manufacturing needs
Through our novel approaches, we have optimized our transfection process to achieve a suspension bioreactor titer of up to 1E15 vg/L nearly 2 orders of magnitude above the industry standard of 1E13 to 1E14 vg/L.
We have also refined our purification process to achieve >90% full vector at all scales up to 2000 L. Guided by innovation, we stay ahead of the learning curve.
Our platform is designed to support a wide range of products
We have demonstrated consistent performance in 800+ batches at different scales with 500+ constructs bearing different serotypes and genomes.
Our team of experts in gene therapy, manufacturing, engineering, and quality bring together years of industry experience
We have significant experience in bringing AAV products into the clinic.
From AAV product development to commercialization, our team will guide you every step of the way.